source
- Qiagen appoints new chief executive after 9-month searchMolecular diagnostics specialist Qiagen has a new CEO as Jonathan M. Pratt takes the reins.Fierce Biotech · 5h ago↗ source
- TME holds onto $1B dream for brain cancer drug as search for partners nears conclusionTME Pharma’s hunt for a partner for its brain cancer drug is closer to bearing fruit as the German biotech clings onto its hope of generating $1 billion in peak sales from the asset.Fierce Biotech · 5h ago↗ source
- Spruce’s successful FDA talks plant seeds for Q4 filing of ultra-rare disease drugSpruce Biosciences has taken another step toward filing for FDA approval of its ultra-rare disease drug candidate, ticking off some of the manufacturing tasks needed to submit the long-awaited appl…